Edgewise Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 11/14/2025 | 15.52 M | $251.71 M | 0.00% | 14.79% |
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2025 | 10.43 M | $169.15 M | 5.31% | 9.94% |
| BAKER BROS. ADVISORS LP | 11/14/2025 | 7.31 M | $118.50 M | 0.00% | 6.96% |
| BLACKROCK, INC. | 11/12/2025 | 6.35 M | $103.02 M | -6.33% | 6.05% |
| PARADIGM BIOCAPITAL ADVISORS LP | 11/14/2025 | 6.17 M | $100.08 M | 0.45% | 5.88% |
| NOVO HOLDINGS A/S | 11/14/2025 | 5.35 M | $86.78 M | 0.00% | 5.10% |
| BRAIDWELL LP | 11/14/2025 | 5.21 M | $84.52 M | 0.00% | 4.97% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 4.98 M | $80.80 M | -9.52% | 4.74% |
| VANGUARD GROUP INC | 11/07/2025 | 4.80 M | $77.92 M | -0.78% | 4.58% |
| CORMORANT ASSET MANAGEMENT, LP | 11/14/2025 | 4.01 M | $65.04 M | -5.69% | 3.82% |
| SIREN, L.L.C. | 11/13/2025 | 3.90 M | $63.21 M | 23.31% | 3.71% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 3.80 M | $61.57 M | -18.19% | 3.62% |
| BELLEVUE GROUP AG | 11/14/2025 | 2.78 M | $45.03 M | 0.00% | 2.65% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 2.23 M | $36.14 M | 6.02% | 2.12% |
| BIOIMPACT CAPITAL LLC | 11/14/2025 | 1.72 M | $27.91 M | 0.00% | 1.64% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.72 M | $27.86 M | -4.43% | 1.64% |
| STATE STREET CORP | 11/14/2025 | 1.70 M | $27.57 M | -4.58% | 1.62% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 11/14/2025 | 1.50 M | $24.33 M | 50.00% | 1.43% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 11/14/2025 | 1.41 M | $22.95 M | -17.45% | 1.35% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 1.18 M | $19.19 M | 12.79% | 1.13% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 1.10 M | $17.77 M | 39.88% | 1.04% |
| NEW LEAF VENTURE PARTNERS, L.L.C. | 11/14/2025 | 1.03 M | $16.71 M | 0.00% | 0.98% |
| MORGAN STANLEY | 11/14/2025 | 869.68 K | $14.11 M | 19.51% | 0.83% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 11/14/2025 | 765.69 K | $12.42 M | -62.96% | 0.73% |
| MILLENNIUM MANAGEMENT LLC | 11/14/2025 | 725.43 K | $11.77 M | -21.32% | 0.69% |
| ARTISAN PARTNERS LIMITED PARTNERSHIP | 11/12/2025 | 718.18 K | $11.65 M | -47.92% | 0.68% |
| D. E. SHAW & CO., INC. | 11/14/2025 | 677.56 K | $10.99 M | 13.79% | 0.65% |
| ABRDN PLC | 11/07/2025 | 619.88 K | $10.05 M | 39.83% | 0.59% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 597.60 K | $9.69 M | 3.19% | 0.57% |
| NORTHERN TRUST CORP | 11/14/2025 | 587.88 K | $9.54 M | -2.49% | 0.56% |
| EVENTIDE ASSET MANAGEMENT, LLC | 11/14/2025 | 568.31 K | $9.22 M | 0.00% | 0.54% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2025 | 555.71 K | $9.01 M | 11.16% | 0.53% |
| PARKMAN HEALTHCARE PARTNERS LLC | 11/14/2025 | 550.17 K | $8.92 M | -15.01% | 0.52% |
| CITIGROUP INC | 11/10/2025 | 538.45 K | $8.73 M | -25.72% | 0.51% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 527.83 K | $8.56 M | -16.45% | 0.50% |
| SOFINNOVA INVESTMENTS, INC. | 11/14/2025 | 520.24 K | $8.44 M | -27.43% | 0.50% |
| EVERSEPT PARTNERS, LP | 11/14/2025 | 502.23 K | $8.15 M | 27.88% | 0.48% |
| OPALEYE MANAGEMENT INC. | 11/14/2025 | 500.00 K | $8.11 M | 2.04% | 0.48% |
| VICTORY CAPITAL MANAGEMENT INC | 11/12/2025 | 498.65 K | $8.09 M | 12.60% | 0.48% |
| TANG CAPITAL MANAGEMENT LLC | 11/14/2025 | 431.30 K | $7.00 M | 0.00% | 0.41% |
| GRANAHAN INVESTMENT MANAGEMENT, LLC | 11/14/2025 | 339.62 K | $5.51 M | -16.24% | 0.32% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 321.13 K | $5.21 M | 26.22% | 0.31% |
| SIO CAPITAL MANAGEMENT, LLC | 11/13/2025 | 307.18 K | $4.98 M | -43.09% | 0.29% |
| KYNAM CAPITAL MANAGEMENT, LP | 11/14/2025 | 253.98 K | $4.12 M | 0.00% | 0.24% |
| FMR LLC | 11/13/2025 | 253.33 K | $4.11 M | -46.18% | 0.24% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/13/2025 | 250.62 K | $4.07 M | -0.75% | 0.24% |
| BARCLAYS PLC | 11/12/2025 | 234.65 K | $3.81 M | -16.57% | 0.22% |
| WOODLINE PARTNERS LP | 11/14/2025 | 224.19 K | $3.64 M | -79.56% | 0.21% |
| CANDRIAM S.C.A. | 11/06/2025 | 221.16 K | $3.59 M | -1.26% | 0.21% |
| NEUBERGER BERMAN GROUP LLC | 11/12/2025 | 219.65 K | $3.56 M | 32.69% | 0.21% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Edgewise Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 209 institutional investors and hedge funds held shares of Edgewise Therapeutics, Inc.. The most heavily invested institutionals were:
ORBIMED ADVISORS LLC: 15.52 M
RA CAPITAL MANAGEMENT, L.P.: 10.43 M
BAKER BROS. ADVISORS LP: 7.31 M
BlackRock, Inc.: 6.35 M
Paradigm Biocapital Advisors LP: 6.17 M
Novo Holdings A/S: 5.35 M
106.69% of Edgewise Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 118.90 M shares in the last 24 months. This purchase volume represents approximately $1.86 B in transactions.